Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean D Sullivan

Showing results (241-250 of 325) with videos related to

Pageof 33
Sort By:
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Examining the value and quality of health economic analyses: implications of utilizing the QHESJoshua J Ofman, Sean D Sullivan, Peter J Neumann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 5, 2008
Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapyScott D Ramsey, Zhimei Liu, Rob Boer, et al.
Diabetes, Obesity & Metabolism|July 31, 2020
A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control studyLuigi F Meneghini, Sean D Sullivan, Gerry Oster, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 16, 2014
Mapping a patient-reported functional outcome measure to a utility measure for comparative effectiveness and economic evaluations in older adults with low back painSean D Rundell, Brian W Bresnahan, Patrick J Heagerty, et al.
Applied Health Economics and Health Policy|July 10, 2014
Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastasesBrian Seal, Sean D Sullivan, Scott D Ramsey, et al.
The Journal of Allergy and Clinical Immunology|December 6, 2003
Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthmaSean D Sullivan, Martin Buxton, L Fredrik Andersson, et al.
The American Journal of Managed Care|December 1, 2015
Private sector risk-sharing agreements in the United States: trends, barriers, and prospectsLouis P Garrison, Josh J Carlson, Preeti S Bajaj, et al.
Gene Therapy|October 31, 2023
A practical approach for adoption of a hub and spoke model for cell and gene therapies in low- and middle-income countries: framework and case studiesShadi Saleh, Omar Dabbous, Sean D Sullivan, et al.
Journal of Managed Care & Specialty Pharmacy|June 23, 2022
Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United StatesNina Kim, Jessie Wang, Chakkarin Burudpakdee, et al.
Diabetes, Obesity & Metabolism|June 26, 2018
Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort studySean D Sullivan, Timothy S Bailey, Ronan Roussel, et al.
Pageof 33

Showing results (241-250 of 325) with videos related to

Sort By:
Pageof 33
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Examining the value and quality of health economic analyses: implications of utilizing the QHESJoshua J Ofman, Sean D Sullivan, Peter J Neumann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 5, 2008
Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapyScott D Ramsey, Zhimei Liu, Rob Boer, et al.
Diabetes, Obesity & Metabolism|July 31, 2020
A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control studyLuigi F Meneghini, Sean D Sullivan, Gerry Oster, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 16, 2014
Mapping a patient-reported functional outcome measure to a utility measure for comparative effectiveness and economic evaluations in older adults with low back painSean D Rundell, Brian W Bresnahan, Patrick J Heagerty, et al.
Applied Health Economics and Health Policy|July 10, 2014
Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastasesBrian Seal, Sean D Sullivan, Scott D Ramsey, et al.
The Journal of Allergy and Clinical Immunology|December 6, 2003
Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthmaSean D Sullivan, Martin Buxton, L Fredrik Andersson, et al.
The American Journal of Managed Care|December 1, 2015
Private sector risk-sharing agreements in the United States: trends, barriers, and prospectsLouis P Garrison, Josh J Carlson, Preeti S Bajaj, et al.
Gene Therapy|October 31, 2023
A practical approach for adoption of a hub and spoke model for cell and gene therapies in low- and middle-income countries: framework and case studiesShadi Saleh, Omar Dabbous, Sean D Sullivan, et al.
Journal of Managed Care & Specialty Pharmacy|June 23, 2022
Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United StatesNina Kim, Jessie Wang, Chakkarin Burudpakdee, et al.
Diabetes, Obesity & Metabolism|June 26, 2018
Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort studySean D Sullivan, Timothy S Bailey, Ronan Roussel, et al.
Pageof 33